Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Join | Sign in
Home>Events

  Events

September 2013
Scientific News
Gene Therapy for Cystic Fibrosis Shows Encouraging Trial Results
A therapy that replaces the faulty gene responsible for cystic fibrosis in patients' lungs has produced encouraging results in a major UK trial.
In Blinding Eye Disease, Trash-Collecting Cells Go Awry, Accelerate Damage
NIH research points to microglia as potential therapeutic target in retinitis pigmentosa.
Boys More Likely to Have Antipsychotics Prescribed, Regardless of Age
NIH-funded study is the first look at antipsychotic prescriptions patterns in the U.S.
Human Trials of Manufactured Blood Within Two Years
The first human trials of lab-produced blood to help create better-matched blood for patients with complex blood conditions has been announced by NHS Blood and Transplant.
New Medication for Alcohol Use Disorder
NIH begins clinical trial investigating a potential treatment for alcohol use disorder.
Behavior Matters: Redesigning the Clinical Trial
A recent meta-analysis of six such clinical trials shows that behavior can have a serious impact on the effectiveness of a treatment and that the currently used DBRCT procedures may not be able to assess the effects of behavior on the treatment.
New Commercial Method for Producing Medical Isotope
The effort to secure a stable, domestic source of a critical medical isotope reached an important milestone this month as scientists demonstrated the production, separation and purification of molybdenum-99 (Mo-99.
NCI-MATCH Trial will Link Targeted Cancer Drugs to Gene Abnormalities
Precision medicine trial will open to patient enrollment in July.
Linking Targeted Cancer Drugs to Gene Abnormalities
Investigators at the NIH have announced a series of clinical trials that will study drugs or drug combinations that target specific genetic mutations.
IAOCR Welcomes Important Initial Step for Regulating European Clinical Trials
New regulation to ensure a more streamlined risk-based approach to the conduct of trials with more public openness about each trial and the results they produce.
Clinical Trial Billing Bootcamp - Houston
23 Sep 2013 - 24 Sep 2013
Houston, TX, USA
Clinical Trial Billing Bootcamp - Houston
23 Sep 2013 - 25 Sep 2013
Copenhagen, Denmark
Advanced Portfolio Management Masterclass for Pharma and Biotech Industry
Advanced Portfolio Management Masterclass for Pharma and Biotech Industry
23 Sep 2013 - 25 Sep 2013
Copenhagen, Denmark
Advanced Portfolio Management Masterclass for Pharma and Biotech Industry
The Recall Challenge: Determining When to Conduct a Recall and Whether to Report It Webinar
24 Sep 2013 - 24 Sep 2013
WEBINAR
The Recall Challenge: Determining When to Conduct a Recall and Whether to Report It Webinar
An Overview of the Accountable Care Movement for Life Science Industry Professionals Webinar
25 Sep 2013 - 25 Sep 2013
WEBINAR
An Overview of the Accountable Care Movement for Life Science Industry Professionals Webinar
Updates on Avoiding Re-Inspection through the FDA’s 13485 Voluntary Audit Submission Pilot Program Webinar
26 Sep 2013 - 26 Sep 2013
WEBINAR
Updates on Avoiding Re-Inspection through the FDA’s 13485 Voluntary Audit Submission Pilot Program Webinar
Your body is 3D, why is your cell culture not?
27 Sep 2013 - 27 Sep 2013
Webinar
Your body is 3D, why is your cell culture not?




<< 1 2 >>
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters